Sham-Controlled Rapid-Acting Neuromodulation for Depression
NCT: NCT07487454 · NOT_YET_RECRUITING
Brief Summary
The goal of this study is to learn whether 5 days of accelerated intermittent theta burst stimulation (iTBS), a rapid form of transcranial magnetic stimulation (TMS), which is a non-invasive procedure that uses magnetic fields to stimulate brain activity, works to treat depression in adults. The main questions it aims to answer are: * Does accelerated iTBS reduce depressive symptoms compared to sham (placebo) stimulation? * Are there measurable brain, biological, and digitally measured emotion changes associated with treatment response? Participants will: * Be randomly assigned to receive either active iTBS or sham stimulation * Receive 10 stimulation sessions per day for 5 consecutive days (total of 50 sessions) * Complete MRI brain scans and EEG recordings before and after treatment * Provide blood and saliva samples to measure biological markers * Complete depression rating scales and questionnaires at baseline, during treatment, and at follow-up visits * Use a secure mobile app to record brief facial and vocal samples during the 5-day treatment and at follow-up visits * Return for follow-up visits at 1 week and at 1, 3, 6, and 12 months after treatment
Frequently Asked Questions
What is Sham-Controlled Rapid-Acting Neuromodulation for Depression?
Sham-Controlled Rapid-Acting Neuromodulation for Depression is a clinical trial registered under NCT07487454. Current status: NOT_YET_RECRUITING.
What is the status of NCT07487454?
The current status of NCT07487454 (Sham-Controlled Rapid-Acting Neuromodulation for Depression) is: NOT_YET_RECRUITING.
When did Sham-Controlled Rapid-Acting Neuromodulation for Depression start?
Sham-Controlled Rapid-Acting Neuromodulation for Depression started on 2026-12.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.